Clinical Trial Update: Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND)

View source ↗

Summary

Clinical trial evaluating tafasitamab in combination with lenalidomide followed by tafasitamab monotherapy in relapsed or refractory diffuse large B-cell lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Monjuvi (tafasitamab)
• Revlimid (lenalidomide)

Snippet

Sponsor: Incyte Biosciences Italy S.r.l | Conditions: DLBCL - Diffuse Large B Cell Lymphoma | Status: RECRUITING